# Nova Anchora funding rounds and investors

As of 5 Nov 2026, Nova Anchora has raised $23M across 1 verified round on record; latest: $23 million funding round led by Viking Global Investors, announced 5 Nov 2026.

A biotechnology company developing a corrective topical protein therapy for dystrophic epidermolysis bullosa (DEB)

Page: https://fireround.dev/companies/nova-anchora

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-11-05 | Funding round | $23 million | Viking Global Investors | Cure EB, DEBRA Research gGmbH, EB Medical Research Foundation (EBMRF), EB Research Partnership (EBRP) | [globenewswire.com](https://www.globenewswire.com/news-release/2026/11/05/3396351/0/en/nova-anchora-announces-23-million-financing-to-advance-topical-collagen-vii-therapy-for-dystrophic-epidermolysis-bullosa.html), [markets.businessinsider.com](https://markets.businessinsider.com/news/stocks/nova-anchora-announces-23-million-financing-to-advance-topical-collagen-vii-therapy-for-dystrophic-epidermolysis-bullosa-1036722036), [biospace.com](https://www.biospace.com/press-releases/nova-anchora-announces-23-million-financing-to-advance-topical-collagen-vii-therapy-for-dystrophic-epidermolysis-bullosa) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.